Bioscience Archives

Arizona’s MedTech sector makes big impact on Bioscience Roadmap

Arizona’s technology community and the Bioscience Roadmap have become driving forces behind the economic success of our state. The industry plays a significant role in almost every sector of the business landscape and the work of its leaders is putting our state on the map as a nationwide contender. Two industries in which technology and… Read More →

TGen ties global fungus to continental drift

Healthcare

Cryptococcus, a type of fungi found worldwide that is responsible annually for upwards of 625,000 deaths, was likely originally spread across the globe in conjunction with continental drift, according to a report by Tgen (the Translational Genomics Research Institute). Cryptococcus — Greek for “hidden sphere” — is a fungus usually found in decaying trees and… Read More →

Collaborative gene impacts Arizona life science sector

On May 12, 2017, Gov. Doug Ducey signed Arizona’s $9.8 billion 2018-2019 budget which provides bonding authority for $1 billion for investments in University Research Infrastructure.  This investment continues a collaboration between the State of Arizona, industry leaders, philanthropists, and Arizona’s universities that is driving the Arizona life science sector towards its goal of becoming… Read More →

TGen’s Dr. Daniel Von Hoff honored by Columbia

Dr. Daniel Von Hoff Distinguished Professor, Physician-In-Chief, and Director of Molecular Medicine at the Translational Genomics Research Institute (TGen) will receive a gold medal for excellence in clinical medicine from his alma mater, Columbia University. Columbia University College of Physicians and Surgeons Alumni Association will presentthe award May 13 in New York City to Dr.… Read More →

Banner Health and Mayo researchers target Parkinson’s disease

Researchers at Banner Sun Health Research Institute and Mayo Clinic are continuing to study how to diagnose early Parkinson’s disease. The research team’s most recent article titled, “Peripheral Synucleinopathy in Early Parkinson’s Disease: Submandibular Gland Needle Biopsy Findings” has been recognized by Movement Disorders, the official journal of the International Parkinson and Movement Disorders Society,… Read More →

Arizona Senate passes $1B boost for university research

At 11:01 p.m. on Thursday May 4, 2017, the Arizona Senate passed HB 2547: university infrastructure capital financing; appropriations paving the way for up to $1 billion in bonds to expand and maintain university research infrastructure at Arizona’s public universities. HB2547 is part of a set of budget bills that make up Arizona’s $9.8 Billion Budget… Read More →

TGen and UNC Lineberger shed light on aggressive brain cancer

Two studies by researchers at the Translational Genomics Research Institute (TGen) and the University of North Carolina Lineberger Comprehensive Cancer Center (UNC Lineberger) provide insight on the evolution of glioblastoma and how to potentially combat this most aggressive brain tumor. Both studies were published recently in the scientific journal Neuro-Oncology, and both were funded, in… Read More →

Axolotl Biologix expands product line for wound care

Axolotl Biologix today announced that it has begun shipping its second amniotic allograft product, AxoBioMembrane™, to meet a wide range of wound care needs. Axolotl Biologix, an innovator in regenerative medicine technologies that improve patient outcomes with less pain and lower costs, developed AxoBioMembrane, a dehydrated human amniotic membrane allograft that helps accelerate and improve… Read More →

UA researchers land $2.27M grant to study Valley fever

Why are some people barely affected by Valley fever while others are admitted to intensive care? The search for answers to those questions is on, thanks to a $2.27 million grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health to the University of Arizona Valley Fever… Read More →

Banner MD Anderson offers drug for neuroendocrine cancer

A new option for patients with a rare gastrointestinal tumor now is available at Banner MD Anderson Cancer Center in Gilbert as part of an expanded access clinical trial. The investigational drug is available to eligible patients with inoperable neuroendocrine carcinoma of midgut origin (carcinoid of the digestive tract), offering an alternative for patients who… Read More →

TGen concussion study may lead to better diagnosis, treatment

TGen concussion study of ASU football players
by in Bioscience | Healthcare

A three-year study of the Arizona State University football team will help researchers develop tools to better diagnose and prevent sports-related concussions and other injuries or diseases. The study, conducted by the Translational Genomics Research Institute, drew data from sensors placed inside players’ helmets during practices and games from 2013 to 2016. It combined the… Read More →

Flinn Foundation program picks 7 bioscience startups

Seven Arizona bioscience startup firms were competitively selected to participate in the 2017 Flinn Foundation Bioscience Entrepreneurship Program, which was established to foster entrepreneurship and help early-stage bioscience companies develop into successful and sustainable businesses in Arizona. The firms—based in Flagstaff, Phoenix, Scottsdale, Tempe and Tucson—will receive $30,000 each in funding support and program services… Read More →

BestCompaniesAZ names 100 Best Companies in Arizona

It is the purpose of BestCompaniesAZ and our calling – and has been for 15 years. We knew that better workplaces would create better lives, better communities, and more profitable businesses. Although it wasn’t about the money, the financial success was proven to be a benefit for best companies. Ten years ago, we were excited… Read More →

Colleen’s Dream helps TGen cancer research

Colleen’s Dream Foundation, a Scottsdale-based nonprofit, today announced a $30,000 grant to the Translational Genomics Research Institute (TGen) to research new ways of treating ovarian cancer. The grant will help fund research that builds on TGen’s discovery that mutations in a gene known as SMARCA4 drive a specific type of extremely aggressive ovarian cancer —… Read More →